SEC Form 4 · accession 0001144204-17-009375
REPROS THERAPEUTICS INC. · RPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Wyllie
Director
Period of report
Feb 13, 2017
Accepted (ET)
Feb 15, 2017 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000897075
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 13, 2017 | A | 40,000 | — | A | 49,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of Restricted Stock Units (RSUs), representing the right to receive one share of the issuer's common stock for each vested RSU, that were awarded on February 13, 2017 as compensation to non-employee members of the Board of Directors. The RSUs shall vest in thirty-six (36) equal increments on the last day of each calendar month from February 2017 through January 2020.